InspireMD, Inc.
NSPR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $2,523 | $1,778 | $1,529 | $1,949 |
| % Growth | 41.9% | 16.3% | -21.5% | – |
| Cost of Goods Sold | $1,659 | $1,465 | $1,237 | $1,480 |
| Gross Profit | $864 | $313 | $292 | $469 |
| % Margin | 34.2% | 17.6% | 19.1% | 24.1% |
| R&D Expenses | $3,635 | $3,834 | $4,059 | $3,693 |
| G&A Expenses | $5,888 | $5,326 | $4,943 | $4,228 |
| SG&A Expenses | $10,280 | $9,498 | $7,693 | $6,143 |
| Sales & Mktg Exp. | $4,392 | $4,172 | $2,750 | $1,915 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $13,915 | $13,332 | $11,752 | $9,836 |
| Operating Income | -$13,051 | -$13,019 | -$11,460 | -$9,367 |
| % Margin | -517.3% | -732.2% | -749.5% | -480.6% |
| Other Income/Exp. Net | $343 | -$132 | $294 | $252 |
| Pre-Tax Income | -$12,708 | -$13,151 | -$11,166 | -$9,115 |
| Tax Expense | $0 | $0 | $0 | $59 |
| Net Income | -$12,708 | -$13,151 | -$11,166 | -$9,174 |
| % Margin | -503.7% | -739.7% | -730.3% | -470.7% |
| EPS | -0.17 | -0.26 | -0.22 | -0.19 |
| % Growth | 34.6% | -18.2% | -15.8% | – |
| EPS Diluted | -0.17 | -0.26 | -0.22 | -0.19 |
| Weighted Avg Shares Out | 73,467 | 51,004 | 49,994 | 48,890 |
| Weighted Avg Shares Out Dil | 73,467 | 51,004 | 49,994 | 48,890 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $294 | $252 |
| Interest Expense | $0 | $132 | $0 | $0 |
| Depreciation & Amortization | $107 | $107 | $98 | $75 |
| EBITDA | -$12,601 | -$12,912 | -$11,362 | -$9,292 |
| % Margin | -499.4% | -726.2% | -743.1% | -476.8% |